Nitric oxide and cerebral ischemia.
Verrecchia
C
C
Laboratoire de Pharmacologie, Université René Descartes, Paris, France.
Buisson
A
A
Lakhmeche
N
N
Plotkine
M
M
Boulu
R G
RG
D000594:Amino Acid Oxidoreductases / Q000037:antagonists & inhibitors; D000704:Analysis of Variance; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002544:Cerebral Infarction / Q000517:prevention & control*; D016291:Dizocilpine Maleate / Q000494:pharmacology; D002546:Ischemic Attack, Transient / Q000378:metabolism / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008981:Molsidomine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D019331:NG-Nitroarginine Methyl Ester; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase; D014665:Vasodilator Agents / Q000494:pharmacology
D014665:Vasodilator Agents; D009569:Nitric Oxide; C002385:linsidomine; D016291:Dizocilpine Maleate; D001120:Arginine; D008981:Molsidomine; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases; D019331:NG-Nitroarginine Methyl Ester